✦ LIBER ✦
A 10% ready-to-use intravenous human immunoglobulin offers potential economic advantages over a lyophilized product in the treatment of primary immunodeficiency
✍ Scribed by C. G. M. Kallenberg
- Book ID
- 108699720
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 131 KB
- Volume
- 150
- Category
- Article
- ISSN
- 0009-9104
No coin nor oath required. For personal study only.